Stocks in news: Ashok Leyland, Mankind Pharma, Vedanta, Lupin, Paradeep Phosphates
Ashok Leyland, Mankind Pharma, Vedanta, Lupin, Paradeep Phosphates among others will be in focus due to various developments.
Ashok Leyland
The Board of Ashok Leyland has declared an interim dividend of Rs 4.95 per share for the financial year ending 2023-24.
Mankind Pharma
Biege is likely to sell up to 2.9% stake in Mankind Pharma through block deals on Tuesday, according to various reports.
JSW Energy
JSW Energy’s arm JSW Renewable Energy (Coated) signed a business transfer agreement (BTA) with Reliance Power for purchase of the 45 MW Vashpet wind project for Rs 132 crore.
Sanghi Industries
Ambuja Cements has sold about 2% stake of Sanghi Industries in the open market to achieve minimum public shareholding.
RIL
The Board RIL approved 100% equity purchase of MSKVY 19 Solar SPV and MSKVY 22 Solar SPV from MSEB Solar Agro Power in accordance with the terms of the tender awarded to the company.
Vedanta
Mining conglomerate Vedanta is looking to invest $6 billion across businesses that span from aluminium and zinc to iron ore, steel and oil and gas as it looks to add at least $2.5 billion to annual EBITDA.
Paytm
Praveen Sharma has resigned from the post of SVP — Business of One 97 Communications with effect from March 31.
Tech Mahindra
Tech Mahindra said it plans to merge its two wholly-owned subsidiaries, Born Group and Tech Mahindra (Americas), to synergise business operations, optimise operational cost, and reduce compliance risks.
Paradeep Phosphates
The central pollution control board (CPCB) has issued a
